Literature DB >> 20822714

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis involving the central nervous system: case report and review of the literature.

A Ghinoi1, G Zuccoli, N Pipitone, C Salvarani.   

Abstract

OBJECTIVES: To report a case of biopsy-proven, ANCA-associated vasculitis (AAV) involving the central nervous system (CNS) and to review the relevant literature.
METHODS: Descriptive case report of one patient with AAV-related CNS vasculitis and review of the relevant literature (PubMed search from 1966 to February 2010).
RESULTS: A 61-year-old female patient with AAV developed cognitive impairment. Cerebrospinal fluid analysis was unremarkable, while magnetic resonance (MR) imaging showed multiple left hemisphere infarctions and MR angiography revealed multiple stenoses of the distal branches of the left median cerebral artery. Treatment with glucocorticoids, cyclophosphamide, and intravenous immunoglobulins led to improvement. CNS vasculitis often arises when vasculitis is active elsewhere. There is no clear preponderance of gender or of age of onset. Both ANCA-positive and -negative cases of CNS vasculitis are documented. The diagnosis is usually based on clinical CNS manifestations and multiple ischaemic (sometimes haemorrhagic) MR lesions mainly affecting the white matter. Angiography is often negative. Treatment with glucocorticoids and cyclophosphamide, sometimes with adjunctive intravenous immunoglobulins, usually improves clinical features and MR lesions.
CONCLUSIONS: AAV rarely involves the CNS. CNS vasculitis should be suspected if patients have neurological manifestations consistent with CNS involvement, particularly if they have evidence of disease activity elsewhere, and if MR shows multiple ischaemic (sometimes haemorrhagic) lesions mainly affecting the white matter. Sepsis, coagulation disorders, and severe hypertension must be ruled out. Awareness of this rare but severe complication can allow early recognition and prompt treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20822714

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Central nervous system involvement in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a study of 29 cases in a single Chinese center.

Authors:  Tian-Tian Ma; Zhi-Ying Li; Yu-Shan Geng; Min Chen; Ming-Hui Zhao
Journal:  Clin Rheumatol       Date:  2020-02-16       Impact factor: 2.980

2.  Proteinase 3 Induces Neuronal Cell Death Through Microglial Activation.

Authors:  Kyu Suk Cho; Eun Joo Lee; Jung Nam Kim; Ji Woong Choi; Hahn Young Kim; Seol-Heui Han; Jong Hoon Ryu; Jae Hoon Cheong; Chan Young Shin; Kyoung Ja Kwon
Journal:  Neurochem Res       Date:  2015-09-08       Impact factor: 3.996

3.  Intracerebral hemorrhage after IV tPA for stroke as early symptom of ANCA-associated vasculitis.

Authors:  Neda Zarghami Esfahani; Daniel M Anderson; Connie Pieper; Harold P Adams
Journal:  eNeurologicalSci       Date:  2017-09-01

4.  Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes.

Authors:  Chunjia Li; Yu Zou; Xin Lu; Guochun Wang; Xiaoming Shu
Journal:  Ther Adv Chronic Dis       Date:  2020-06-09       Impact factor: 5.091

5.  Rheumatoid Cerebral Vasculitis in a Patient in Remission.

Authors:  Georges El Hasbani; Hala El Ouweini; Fatema Dabdoub; Roula Hourani; Ali Sm Jawad; Imad Uthman
Journal:  Clin Med Insights Case Rep       Date:  2022-03-09

6.  Vascular and Vasogenic Manifestations of Systemic ANCA-Associated Vasculitis with Renal Involvement in Non-Contrast Brain MRI in Patients with Acute Disease Onset.

Authors:  Arkadiusz Lubas; Jacek Staszewski; Artur Maliborski; Magdalena Mosakowska; Grzegorz Spłocharski; Anna Bilbin-Bukowska; Izabela Wołoszyńska; Renata Piusińska-Macoch; Daniel Pałka; Arkadiusz Zegadło; Stanisław Niemczyk
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

Review 7.  Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases.

Authors:  Luca Seitz; Pascal Seitz; Roxana Pop; Fabian Lötscher
Journal:  Curr Rheumatol Rep       Date:  2022-09-27       Impact factor: 4.686

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.